Wall Street brokerages expect that Nabriva Therapeutics plc (NASDAQ:NBRV) will report earnings per share (EPS) of ($0.94) for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Nabriva Therapeutics’ earnings, with the lowest EPS estimate coming in at ($1.10) and the highest estimate coming in at ($0.78). Nabriva Therapeutics […]
